FDA quietly shelves Trump’s flagship drug fast-track program amid reports of agency chaos
In brief
The Food and Drug Administration has shelved the fast-track drug review initiative launched during the Trump administration by former Commissioner Marty Makary
This is a summary provided by The Independent — World. Read the complete story on the publisher’s website.
Continue reading at The Independent — World ↗
